Please use this identifier to cite or link to this item:
|Title:||Real-world appropriateness of imaging severity thresholds in interstitial lung disease clinical trials.||Austin Authors:||Ryerson, Christopher J;Goh, Nicole S L||Affiliation:||Department of Medicine, University of British Columbia, Vancouver V5Z 1M9, BC, Canada
Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.
Institute for Breathing and Sleep, Austin Health, Heidelberg, Victoria, Australia
Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia
University of Melbourne, Melbourne, VIC, Australia
|Issue Date:||Feb-2020||Publication information:||The Lancet. Respiratory medicine 2020; 8(2): e7||URI:||http://ahro.austin.org.au/austinjspui/handle/1/22557||DOI:||10.1016/S2213-2600(20)30004-7||ORCID:||0000-0003-2065-4346||PubMed URL:||32035069||Type:||Journal Article|
|Appears in Collections:||Journal articles|
Show full item record
checked on Dec 2, 2022
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.